GLP-1 weight loss drugs linked to lower breast cancer incidence in large cohort study. Study of more than 110,000 women found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications.

GLP-1 weight loss drugs linked to lower breast cancer incidence in large cohort study. Study of more than 110,000 women found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications.